一种源自海胆毒素的肽类化合物,通过激活JNK/JunB信号通路,在卵巢癌中发挥抗肿瘤作用。
A conotoxin-derived peptide exerts anti-tumor effects in ovarian cancer associated with activation of JNK/JunB signaling
Jiawei Xu, Zihui Chen, Jianda Yue, Na Xiao, Wangfei Xiang, Ying Wang, Zhonghua Liu
Journal:BIOCHEMICAL PHARMACOLOGY
IF:6.5
DOI:10.1016/j.bcp.2026.118505
PMID:42801994
Published:2026-09-27
research field:心血管病理学单细胞生物学免疫学空间生物学感染性疾病转录组学
Abstract
The discovery of potent anticancer peptides (ACPs) represents a crucial avenue in current targeted tumor therapy. This study systematically evaluated the broad-spectrum antitumor potential of sPep2, a peptide derived from Conus venom. In vitro investigations demonstrated that sPep2 exhibited potent cytotoxic activity against cancer cells from diverse tissue origins. Notably, its efficacy against ovarian cancer cells was comparable to that of melittin, with a more favorable in vitro selectivity profile. Beyond direct cytotoxicity, sPep2 at sublethal concentrations significantly inhibited tumor cell proliferation. Mechanistic studies indicated that sPep2-induced apoptosis was associated with activation of c-Jun N-terminal kinase (JNK) signaling, accompanied by the upregulation and accumulation of JunB—a member of the activator protein 1 (AP-1) transcription factor family—whereas c-Jun remained unchanged. Furthermore, in vivo ovarian cancer models showed that sPep2 exhibited favorable antitumor efficacy without overt treatment-related toxicity. In conclusion, this study not only identifies sPep2 as a promising hit molecule with broad-spectrum anticancer activity but also suggests that its effects are associated with activation of JNK/JunB signaling. Download: Download high-res image (92KB) Download: Download full-size image
本文使用的Yeasen产品
南美超级胎牛血清999尝鲜特惠


